- Aliskiren lowers proteinuria in patients with diabetic nephropaty treatedly angiotenzin antagonists2009 | First Faculty of Medicine
- Continued treatment of ACE inhibitors and angiotenzin antagonist in diabetic nephropathy2005 | First Faculty of Medicine
- Are Angiotenzin-Converting Enzyme Inhibitors and Angiotensin Antagonists Really Reprotective?2006 | First Faculty of Medicine
- Combination of ACE inhibitors and angiotenzin antagonists in patients with chronic kidney disease2006 | First Faculty of Medicine
- Dual blocade of the renin-angiotensin and proteinuria2008 | First Faculty of Medicine
- Should renin-angiotensin system inhibitors be discontinued in patients with covid-19 infection?2022 | First Faculty of Medicine
- Angiotensin converting enzyme inhibitors in nephrology2019 | First Faculty of Medicine
- The effect of treatment with angiotenzin - converting enzyme inhibitors and angiotensin antagonist on progression of chronic nephropathy2002 | First Faculty of Medicine
- Angiotensin-converting enzyme inhibitor-induced angioedema2019 | First Faculty of Medicine, Second Faculty of Medicine
- Treatment with ACE inhibitors and AT1-blockers during the COVID-19 pandemic2020 | Faculty of Medicine in Hradec Králové
- Editorial: Diuretic increase the antiproteinurie effect of ACE inhibitors and angiotenzin antagonist2005 | First Faculty of Medicine
- Inhibitors of Angiotensin converting Enzyme and Antagonists in Patients with chronic nephrosis disease2004 | First Faculty of Medicine
- Angiotensin converting enzyme inhibitors and angiotensin antagonists in the treatment of diabetic nephropathy2002 | First Faculty of Medicine
- Low levels of angiotensin converting enzyme to prevent type 2 diabetes2020 | Second Faculty of Medicine
- Can the progression of chronic kidney disease be influenced by the treatment with angiotenzi antagonists?2004 | First Faculty of Medicine
- Are angiotensin II antagonists renoprotective (in Czech)?2000 | First Faculty of Medicine
- ICE inhibitors and angiotenzin antagonists are still underused in elderly patients with diabetes2006 | First Faculty of Medicine
- Experimental Ischaemic Renal Injury - Role of Surgical Technique and Protective Effect of Non-peptic Angiotensin II Antagonist (losartan)2000 | Publication without faculty affiliation
- The renin-angiotension system and arterial hypertension2004 | First Faculty of Medicine
- Inhibitors of the Angiotensin Converting Enzyme in the Therapy and Secondary Prevention of the Myocardial Infarction2002 | Third Faculty of Medicine
- Progression of Cronic Renal Insufficiency and Possibilities to Influence it by Inhibitors of the Angiotensin Convrting Enzyme and Angiotensin Antagonists2003 | First Faculty of Medicine
- Angiotensin II receptor blockers in the treatment of chronic heart failurePublication without faculty affiliation
- Angiotensin II receptor atagonists type AT1 (AT1 blockers)2008 | First Faculty of Medicine
- ACE-inhibitors and mortality in hypertension: metaanalysis of radnomised clinical trials of renin-angiotensin-aldosterone inhibitors2012 | First Faculty of Medicine
- Inhibice osy renin-angiotenzin-aldosteron-jsou rozdíly ve strategii, jsou rozdíly mezi léčivy?2014 | First Faculty of Medicine, Third Faculty of Medicine
- The role of angiotensin II-receptor blockers, type A1 in the therapy of arterial hypertension2003 | First Faculty of Medicine
- Diabetici 2. typu s akutním vzestupem koncentrace kreatininu v séru po zahájení léčby inhibitorem angiotenzin konvertujícího enzymu (ACEI) by měli v léčbě ACEI pokračovat2019 | First Faculty of Medicine
- Antagonists of the renin-angiotensin-aldosterone system2011 | First Faculty of Medicine
- The role of angiotensin II type 1 receptor blockers (sartans) in the prevention of cardiovascular disease2005 | Faculty of Medicine in Pilsen
- The role of angiotensin II type 1 receptor blockers in the prevention of cardiovascular disease. Editorial2005 | Faculty of Medicine in Pilsen